乳腺癌骨转移相关临床特征的研究进展

周 雪莹, 李 　翊, 崔 家咏, 赵福 星*, 沈国 双*
青海大学附属医院

摘要


乳腺癌以67万死亡例数超越胃癌成为全球第四大癌症杀手。骨转移（Bone Metastasis，BM）是晚期乳腺癌
（Breast Cancer，BC）患者最常见的转移部位。本综述深入探讨了乳腺癌骨转移的相关临床特征的研究进展。结合最
新的研究进展我们综合概述了临床研究中发现的乳腺癌患者骨转移特征，包括年龄、激素、TNM分期等相关特征。
通过本文，可以在临床上更好的识别患者骨转移风险特征，从而使骨转移患者得到早期的诊治。

关键词


乳腺癌；骨转移；临床特征

全文:

PDF


参考


[1]HAN B, ZHENG R, ZENG H, 等 . Cancer

incidence and mortality in China, 2022[J/OL]. Journal of the

National Cancer Center, 2024, 4(1): 47-53. DOI:10.1016/

j.jncc.2024.01.006.

[2]ROMMASI F. Identification, characterization, and

prognosis investigation of pivotal genes shared in different

stages of breast cancer[J/OL]. Scientific Reports, 2023, 13(1):

8447. DOI:10/gr9sk8.

[3]NGUYEN M N, AKTER S, AKHTER H, 等 .

TOR1B: a predictor of bone metastasis in breast cancer

patients[J/OL]. Scientific Reports, 2023, 13(1): 1495.

DOI:10.1038/s41598-023-28140-y.

[4]ZHAO Z, YANG H, JI G, 等. Identification of

hub genes for early detection of bone metastasis in breast

cancer[J/OL]. Frontiers in Endocrinology, 2022, 13: 1018639.

DOI:10.3389/fendo.2022.1018639.

[5]PARKES A, WARNEKE C L, CLIFTON K, 等.

Prognostic Factors in Patients with Metastatic Breast Cancer

with Bone-Only Metastases[J/OL]. The Oncologist, 2018,

23(11): 1282-1288. DOI:10.1634/theoncologist.2018-0085.

[6]ZHANG Y, HE W, ZHANG S. Seeking for

Correlative Genes and Signaling Pathways With Bone

Metastasis From Breast Cancer by Integrated Analysis[J/

OL]. Frontiers in Oncology, 2019, 9: 138. DOI:10.3389/

fonc.2019.00138.

[7]KAN C, VARGAS G, PAPE F, 等. Cancer Cell

Colonisation in the Bone Microenvironment[J/OL].

International Journal of Molecular Sciences, 2016, 17(10):

1674. DOI:10.3390/ijms17101674.

[8]CHEN W Z, SHEN J F, ZHOU Y, 等. Clinical

characteristics and risk factors for developing bone metastases

in patients with breast cancer[J/OL]. Scientific Reports, 2017,

7(1): 11325. DOI:10.1038/s41598-017-11700-4.

[9]COLEMAN R E, CROUCHER P I, PADHANI

A R, 等. Bone metastases[J/OL]. Nature Reviews. Disease

Primers, 2020, 6(1): 83. DOI:10.1038/s41572-020-

00216-3.

[10]HIRAGA T. Bone metastasis: Interaction between

cancer cells and bone microenvironment[J/OL]. Journal

of Oral Biosciences, 2019, 61(2): 95-98. DOI:10.1016/

j.job.2019.02.002.

[11]SAVCI-HEIJINK C D, HALFWERK H,

KOSTER J, 等. A novel gene expression signature for bone

metastasis in breast carcinomas[J/OL]. Breast Cancer Research

and Treatment, 2016, 156(2): 249-259. DOI:10.1007/

s10549-016-3741-z.

[12]HUANG B, WU F C, WANG W D, 等. The

prognosis of breast cancer patients with bone metastasis

could be potentially estimated based on blood routine test

and biochemical examination at admission[J/OL]. Annals of

Medicine, 2023, 55(1): 2231342. DOI:10.1080/07853890.202

3.2231342.

[13]RIQUELME M A, CARDENAS E R, JIANG

J X. Osteocytes and Bone Metastasis[J/OL]. Frontiers

in Endocrinology, 2020, 11: 567844. DOI:10.3389/

fendo.2020.567844.

[14]VENETIS K, PICIOTTI R, SAJJADI E, 等. Breast

Cancer with Bone Metastasis: Molecular Insights and Clinical

Management[J/OL]. Cells, 2021, 10(6): 1377. DOI:10.3390/

cells10061377.

[15]MOU H, WANG Z, ZHANG W, 等. Clinical

Features and Serological Markers Risk Model Predicts Overall

Survival in Patients Undergoing Breast Cancer and Bone

Metastasis Surgeries[J/OL]. Frontiers in Oncology, 2021, 11:

693689. DOI:10.3389/fonc.2021.693689.

[16]TODD V M, JOHNSON R W. Hypoxia in bone

metastasis and osteolysis[J/OL]. Cancer Letters, 2020, 489:

144-154. DOI:10.1016/j.canlet.2020.06.004.

[17]GILKES D M, SEMENZA G L. Role of hypoxiainducible factors in breast cancer metastasis[J/OL]. Future

Oncology (London, England), 2013, 9(11): 1623-1636.

DOI:10.2217/fon.13.92.

[18]DIESSNER J, WISCHNEWSKY M, STÜBER

T, 等 . Evaluation of clinical parameters influencing the

development of bone metastasis in breast cancer[J/OL]. BMC

cancer, 2016, 16: 307. DOI:10.1186/s12885-016-2345-7.

[19]LIEDE A, JERZAK K J, HERNANDEZ R

K, 等. The incidence of bone metastasis after early-stage

breast cancer in Canada[J/OL]. Breast Cancer Research and

Treatment, 2016, 156(3): 587-595. DOI:10.1007/s10549-

016-3782-3.

[20]PURUSHOTHAM A, SHAMIL E, CARIATI M,

等. Age at diagnosis and distant metastasis in breast cancer-

-a surprising inverse relationship[J/OL]. European Journal of

Cancer (Oxford, England: 1990), 2014, 50(10): 1697-1705.

DOI:10.1016/j.ejca.2014.04.002.

[21]ZHANG C, QI L, CAI J, 等 . Clinicomicsguided distant metastasis prediction in breast cancer via

artificial intelligence[J/OL]. BMC Cancer, 2023, 23(1): 239.

DOI:10.1186/s12885-023-10704-w.

[22]CHEN J, ZHU S, XIE X Z, 等 . Analysis of

clinicopathological factors associated with bone metastasis

in breast cancer[J/OL]. Journal of Huazhong University of

Science and Technology. Medical Sciences = Hua Zhong Ke

Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong

Keji Daxue Xuebao. Yixue Yingdewen Ban, 2013, 33(1):

122-125. DOI:10.1007/s11596-013-1083-1.

[23]SMID M, WANG Y, KLIJN J G M, 等. Genes

Associated With Breast Cancer Metastatic to Bone[J/OL].

Journal of Clinical Oncology, 2006, 24(15): 2261-2267.

DOI:10.1200/JCO.2005.03.8802.

[24]ZHAO C, LOU Y, WANG Y, 等 . A gene

expression signature-based nomogram model in prediction of

breast cancer bone metastases[J/OL]. Cancer Medicine, 2019,

8(1): 200-208. DOI:10.1002/cam4.1932.

[25]MOLNÁR I A, MOLNÁR B Á, VÍZKELETI

L, 等. Breast carcinoma subtypes show different patterns of

metastatic behavior[J/OL]. Virchows Archiv, 2017, 470(3):

275-283. DOI:10.1007/s00428-017-2065-7.

[26]BENNETT C, CARROLL C, WRIGHT

C, 等 . Breast Cancer Genomics: Primary and Most

Common Metastases[J/OL]. Cancers, 2022, 14(13): 3046.

DOI:10.3390/cancers14133046.

[27]KONO M, FUJII T, MATSUDA N, 等. Somatic

mutations, clinicopathologic characteristics, and survival in

patients with untreated breast cancer with bone-only and

non-bone sites of first metastasis[J/OL]. Journal of Cancer,

2018, 9(19): 3640-3646. DOI:10.7150/jca.26825.

[28]SMID M, WANG Y, ZHANG Y, 等. Subtypes

of Breast Cancer Show Preferential Site of Relapse[J/

OL]. Cancer Research, 2008, 68(9): 3108-3114.

DOI:10.1158/0008-5472.CAN-07-5644.

[29]FAN J H, ZHANG S, YANG H, 等. Molecular

subtypes predict the preferential site of distant metastasis in

advanced breast cancer: a nationwide retrospective study[J/

OL]. Frontiers in Oncology, 2023, 13: 978985. DOI:10.3389/

fonc.2023.978985.

[30]SIHTO H, LUNDIN J, LUNDIN M, 等. Breast

cancer biological subtypes and protein expression predict for

the preferential distant metastasis sites: a nationwide cohort

study[J/OL]. Breast Cancer Research, 2011, 13(5): R87.

DOI:10.1186/bcr2944.

[31]SONI A, REN Z, HAMEED O, 等. Breast Cancer

Subtypes Predispose the Site of Distant Metastases[J/OL].

American Journal of Clinical Pathology, 2015, 143(4): 471-

478. DOI:10.1309/AJCPYO5FSV3UPEXS.

[32]KARATAS M, ZENGEL B, DURUSOY R, 等.

Clinicopathologic features of single bone metastasis in breast

cancer[J/OL]. Medicine, 2021, 100(1): e24164. DOI:10.1097/

MD.0000000000024164.

[33]WANG R, ZHU Y, LIU X, 等 . The

Clinicopathological features and survival outcomes of patients

with different metastatic sites in stage IV breast cancer[J/OL].

BMC Cancer, 2019, 19(1): 1091. DOI:10.1186/s12885-

019-6311-z.

[34]YAMASHIRO H, TAKADA M, NAKATANI

E, 等. Prevalence and risk factors of bone metastasis and

skeletal related events in patients with primary breast cancer

in Japan[J/OL]. International Journal of Clinical Oncology,

2014, 19(5): 852-862. DOI:10.1007/s10147-013-0643-5.


Refbacks

  • 当前没有refback。